Retatrutide is not available on the NHS as it has not received MHRA marketing authorisation
At Peptides Thailand, that is exactly how Retatrutide is provided, with clinical-grade sourcing and proper monitoring, and a physician can also discuss approved alternatives like semaglutide or tirzepatide where they are a better fit for you
If you want maximum results and are tolerating 8 mg without significant issues, proceed to 12 mg
Regular monitoring and lifestyle guidance ensure that each patient receives safe, supportive care throughout their treatment journey
What Real-World Use Suggests According to general patterns observed in telehealth weight loss programs and clinical practice: First 4-8 weeks: Many people experience appetite reduction and early weight loss (often 5-10 pounds, though individual experiences vary widely)
Speak up early to avoid worsening discomfort and unnecessary interruptions in your treatment